Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04267666
Other study ID # CairoU9
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date December 30, 2019

Study information

Verified date February 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: To compare the effectiveness of inspiratory muscle training (IMT) and incentive spirometer on ventilatory functions in post-menopausal asthmatic women. Participants and methods: A total of forty postmenopausal women suffering from asthma, their ages ranged from 50 to 60 years old, and their body mass index of the patient don't exceed 30kg/m2. They were recruited from patient chest clinic in Kasr -El- Ainy Teaching Hospital, Cairo University, Egypt.


Description:

They signed a consent form, confidentiality was assured. They assigned into two groups (A) who received inspiratory muscle training in the form of: Inspiratory threshold muscle trainer in addition to traditional chest physical therapy intervention (Deep breath, cough training) while patients in group (B): received traditional chest physical therapy intervention and incentive spirometer, three sessions per week for six weeks. Patients in both groups were assessed before treatment (pre-training) then after treatment (post-training) (after 6 weeks) to measure lung functions using electronic spirometer. The training program was carried in the duration from January 2019 to July 2019.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 30, 2019
Est. primary completion date December 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years to 60 Years
Eligibility Inclusion Criteria:

- Forty postmenopausal women suffering from asthma

- Their ages were ranged from 50 to 60 years,

- their body mass index (BMI) don't exceed 30kg/m2.

- All participants were asthmatic patient

- clinically and medically stable cases

Exclusion Criteria:

- participant who had chest infection,

- malignant diseases,

- Patients with chest trauma.

Study Design


Intervention

Device:
incentive spirometer
Patient had to produce a high inspiratory pressure. The ball serves as visible feedback of the inspiratory flow and indicates the obtained flow on a calibrated scale on the transparent cylinder of the spirometer. If the patient flows greater than 300 milliliters per second, the float ball in first chamber will rise. As patient flow increases to 600 milliliters per second the second ball float will rise. If the patient flow exceeds 900 milliliters per second all three will be suspended. Patient should encourage holding the balls up for a few seconds
Other:
Inspiratory muscle trainer device
The threshold trainer is a small plastic handheld device supplied by respironics. It includes a mouthpiece and a calibrated spring loaded valve. The valve controls a constant inspiratory pressure training load and the patient must generate the inspiratory pressure in order for the inspiratory valve to be opened and allow inhalation of air.

Locations

Country Name City State
Egypt Ghada Ebrahim Elrefaye Giza Dokki

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Electronic Spirometer (VIASYS- Health Care Microlab) It was used for ventilatory functions measurement Ventilatory,reported as a number in liters (L). 6 weeks
Primary FVC (Forced vital capacity) is one of the most useful tests to assess the overall ability to move air in and out of the lungs (ventilation). This is the maximum amount of air that can be forcefully and rapidly exhaled after a deep breath (maximal inspiration),reported as a number in liters (L) 6 weeks
Primary FEV1 (Forced expiratory volume) is the volume of air forcibly exhaled in one second during the FVC test,reported as a number in liters (L) 6 weeks
Primary MVV (Maximum voluntary ventilation) is the maximum air, which can be expired in a minute by deepest and fastest breathing, reported as a number in liters (L) 6 weeks
Secondary Body mass index It was used for measuring the weight and height of each patient to calculate the body mass index. BIM=weight (Kg) / height (m2). 6 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06369363 - Estrogen Deficiency on Cardiovascular Risk Early Phase 1
Not yet recruiting NCT01170195 - Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms Phase 1/Phase 2
Completed NCT00535288 - Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) Phase 3
Recruiting NCT06030388 - Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women N/A
Not yet recruiting NCT05557799 - Photobiomodulation in Post Menopause Genitourinary Syndrome Phase 1/Phase 2
Recruiting NCT04893226 - Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women N/A
Completed NCT03684096 - Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes N/A
Completed NCT01268046 - Aging and Estrogen on Cortical Function Phase 1/Phase 2
Recruiting NCT05659693 - The Effect of Digital Literacy Education Given to Postmenopausal Women on Health Literacy and Quality of Life N/A
Completed NCT03572153 - A Mind-Body Intervention for Hot Flash Management N/A
Not yet recruiting NCT06419972 - Multimodal Program for Climacteric Women N/A
Not yet recruiting NCT06197568 - Open-Label Study of Vaginal AZU-101 in Postmenopausal Women Phase 1/Phase 2
Withdrawn NCT03854396 - Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women Phase 3
Completed NCT01361308 - Efficacy/Safety Study of Brisdelleā„¢ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) Phase 3
Unknown status NCT00905723 - The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women Phase 3
Recruiting NCT05351476 - Exercise Training and Fat Metabolism in Postmenopausal Women N/A
Completed NCT06096818 - Kegel and Abdominal Exercises on Urinary Incontinence Severity, Quality of Life, and Sleep Quality in Menopausal Women N/A
Completed NCT03150407 - Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness N/A
Recruiting NCT06220266 - Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women Phase 2/Phase 3
Recruiting NCT04129060 - Cholinergic Health After Menopause (CHAMP) Early Phase 1